Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $28K 10.0K sh | Nov 4, 2026 |
| 0 | Santana RafaelDirector, President and CEO |  WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORPOpen-market sale · 10b5-1 plan | SELL | $11K 37 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner |  IBTAIbotta, Inc.Option exercise · 10b5-1 plan | M | — 5,751 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Jordan Joseph HughDirector, Chief Executive Officer |  DPZDOMINOS PIZZA INCOption exercise · 10b5-1 plan | M | — 4,870 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Cowan ElviaSVP, Finance & CAO |  PCVXVaxcyte, Inc.Option exercise · 10b5-1 plan | M | $78K 3,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Daunt JohnEVP, Chief Commercial Officer |  LQDTLIQUIDITY SERVICES INCOption exercise · 10b5-1 plan | M | $8,432 390 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Derivative conversion · 10b5-1 plan | C | — 12.8K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Ring ChristineChief Legal Officer |  NRIXNurix Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 5,786 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Malady KyleEVP and Group CEO-VZ Business |  VZVERIZON COMMUNICATIONS INCOpen-market sale · 10b5-1 plan | SELL | $49K 1,100 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Derivative conversion · 10b5-1 plan | C | — 2,620 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Option exercise · 10b5-1 plan | M | $442K 34.7K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Wampler Kira SchererDirector |  DOCSDoximity, Inc.Derivative conversion · 10b5-1 plan | C | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Krasnow ToddDirector | SYMSymbotic Inc. Other acquisition or disposition · 10b5-1 plan | J | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 5,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Vassil JonathanChief Revenue Officer |  TOSTToast, Inc.Option exercise · 10b5-1 plan | M | — 14.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Wassil JimEVP, Chief Scientific Ofc, COO | PCVXVaxcyte, Inc. Option exercise · 10b5-1 plan | M | $12K 2,250 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Matsuda MasaruEVP, Chief Legal Officer |  ARQTArcutis Biotherapeutics, Inc.Option exercise · 10b5-1 plan | M | — 40.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 0 | Santana RafaelDirector, President and CEO | WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP Open-market sale · 10b5-1 plan | SELL | $46K 158 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Santana RafaelDirector, President and CEO | WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP Open-market sale · 10b5-1 plan | SELL | $19K 66 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Krasnow ToddDirector | SYMSymbotic Inc. Other acquisition or disposition · 10b5-1 plan | J | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Derivative conversion · 10b5-1 plan | C | — 2,620 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Tsuchimoto Kim RDirector |  MNPRMonopar TherapeuticsOption exercise · 10b5-1 plan | M | $36K 1,199 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Anderson RaymondDirector | MNPRMonopar Therapeutics Option exercise · 10b5-1 plan | M | — 1,402 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Krasnow ToddDirector | SYMSymbotic Inc. Other acquisition or disposition · 10b5-1 plan | J | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Bealmear Richard CraigChief Financial Officer | OKLOOklo Inc. Option exercise · 10b5-1 plan | M | $17K 5,369 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Bealmear Richard CraigChief Financial Officer | OKLOOklo Inc. Option exercise · 10b5-1 plan | M | — 16.7K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Tsuchimoto Kim RDirector | MNPRMonopar Therapeutics Option exercise · 10b5-1 plan | M | $26K 856 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Derivative conversion · 10b5-1 plan | C | — 2,620 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Syrvalin Kristine CEVP General Counsel |  MTUSMetallus Inc.Option exercise · 10b5-1 plan | M | $52.38 3 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Option exercise · 10b5-1 plan | M | $38K 4,529 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Raabe Kyle AndrewPresident, Home Power Gen. |  GNRCGENERAC HOLDINGS INC.Option exercise · 10b5-1 plan | M | $22K 212 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Houston AndrewDirector, Co-CEO, 10% Owner |  DBXDROPBOX, INC.Derivative conversion · 10b5-1 plan | C | — 383.8K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Fang AndyDirector | DASHDoorDash, Inc. Other acquisition or disposition · 10b5-1 plan | J | — 4,954 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Derivative conversion · 10b5-1 plan | C | — 2,620 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Fang AndyDirector | DASHDoorDash, Inc. Other acquisition or disposition · 10b5-1 plan | J | — 5,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Hall John TDirector, Chief Executive Officer |  INTAIntapp, Inc.Option exercise · 10b5-1 plan | M | — 3,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Wassenaar YvonneDirector | RBRKRubrik, Inc. Derivative conversion · 10b5-1 plan | C | — 721 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 0 | Raabe Kyle AndrewPresident, Home Power Gen. | GNRCGENERAC HOLDINGS INC. Option exercise · 10b5-1 plan | M | — 212 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Derivative conversion · 10b5-1 plan | C | — 12.8K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 0 | Daunt JohnEVP, Chief Commercial Officer | LQDTLIQUIDITY SERVICES INC Option exercise · 10b5-1 plan | M | — 325 sh | Nov 4, 2026 traded Nov 2, 2026 |